Subject: Three Key Patents Granted To Aid Genetic Research
Date: Published: 1/13/93 (30 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    Technology Brief -- Enzo Biochem Inc.:
    Three Key Patents Granted
    To Aid Genetic Research

    Enzo Biochem Inc. said the U. S. patent office granted the New
 York company three key patents that will enable it to broaden its
 work in the new genetic antisense field.
    Enzo was notified about the first patent in August 1992.  Two
 subsequent patents, to be issued soon, will give Enzo exclusive
 rights to specific procedures and products involved in genetic
 antisense research.
    Antisense technology permits scientists to attach a gene to a
 cell that would regulate the function of another gene in the same
 cell.  Antisense genes have the potential of blocking progress of
 defective genes.  Researchers believe the technology could eventually
 be used to treat various types of cancer, AIDS and other diseases.
    Dr. Elazar Rabbani, Enzo president, told shareholders that
 preliminary discussions have already begun with companies interested
 in licensing the technology for therapeutic and agricultural
 purposes.  Enzo licenses genetic antisense technology from the
 Research Foundation of the State University of New York.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]